La création de ce centre démontre l’engagement de l’entreprise à fournir des solutions adaptées aux défis de la gynécologie et de la pédiatrie SHANGHAI, 25 décembre 2023 /PRNewswire/ — Changchun GeneScience Pharmaceutical (« GenSci »), une filiale de Changchun High-Tech Industries…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.